Understanding the mechanism of Trikatu in type 2 diabetes mellitus and lipid-related metabolic disorders: A network pharmacology approach
Varun Chhabra, Mohit Wadhawan, Amit Katiyar, Bharat Krushna Khuntia, Vandna Sharma, Shubhangi Rathore, Punit Kaur, Gautam Sharma
This paper uses network pharmacology to identify the therapeutic targets and pathways of Trikatu in T2DM and lipid disorders, revealing key molecules and interactions.
bioRxiv · Jun 22, 2022 · PreprintBioinformatics